Clinical Trial Update: Microbiota: Its Role in Chronic Inflammation, IDB and Risk of Colorectal Cancer. Evaluation of a Predictive Prognostic Model With Therapeutic Implications

View source ↗

Summary

This entry notes an ongoing University of Messina clinical trial examining the role of the gut microbiota in chronic inflammation and colorectal cancer risk, in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Inflammatory Bowel Disease

Snippet

Sponsor: University of Messina | Conditions: IBD (Inflammatory Bowel Disease), Colon Cancer | Status: ACTIVE_NOT_RECRUITING